All cancer types
Results
Phase 1
This study looked at capivasertib (AZD5363) for solid tumours that continued to grow despite all other standard treatments.
Recruitment start: 9 December 2013
Recruitment end: 24 November 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Udai Banerji
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 05 Mar 2019
CRUK internal database number: 7074
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
